Albania's Most-Favored-Nation (MFN) tariff rates for pharmaceutical products under Harmonized System (HS) codes 3003 and 3004 are set at 0% for imports from all countries, including India. This zero-duty rate applies to medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (HS 3003), as well as to medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale (HS 3004). (dogana.gov.al)
Albania has established preferential duty rates under various trade agreements. Notably, the Free Trade Agreement (FTA) between Albania and the European Free Trade Association (EFTA) member states—Liechtenstein, Switzerland, Norway, and Iceland—entered into force on 1 November 2010. This agreement abolished customs duties on industrial products, including pharmaceuticals, originating from the EFTA states. However, as India is not a member of EFTA, these preferential rates do not apply to Indian pharmaceutical exports to Albania. (efta.int)
Regarding anti-dumping or countervailing duty measures, there is no publicly available information indicating that Albania has imposed such measures on Indian pharmaceutical products. Albania's trade policies are generally aligned with its commitments under the World Trade Organization (WTO), which discourages the use of anti-dumping and countervailing duties except in specific circumstances.
